Long-term changes in ADAS-Cog: What is clinically relevant for disease modifying trials in alzheimer?

Journal of Nutrition, Health and Aging

Volumn 11, Issue 4, 2007, Pages 338-341

  Vellas, B ^a,d,e   Andrieu, S ^a,e   Cantet, C ^a,e   Dartigues, J F ^b   Gauthier, S ^c   Rainfray, M ^e   Richard Harston, S ^e   Franco, A ^e   Couturier, P ^e   Pasquier, F ^e   Mackowiak Cordohani, M A ^e   Frigard, B ^e   Idiri, H ^e   Gallouj, K ^e   Michel, B ^e   Jeandel, Cl ^e   Touchon, J ^e   Portet, F ^e   Lerouge, S ^e   Robert, Ph ^e   Brocker, P ^e   Bertogliati, C ^e   Forette, B ^e   Teillet, L ^e   Lechowski, L ^e   Belmin, J ^e   Pariel Madjlessi, D S ^e   Verny, M ^e   Artaz, M A ^e   Forette, F ^e   Rigaud, A S ^e   Latour, F ^e   Jouanny, P ^e   Belliard, S ^e   Michel, O ^e   Girtanner, C ^e   Anterion, Thomas ^e   Ousset, ^e   Cortes, F ^e   Gillette Guyonnet, S ^e   Nourhashemi, F ^e   more..

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c MCGILL UNIVERSITY   (Canada)

^d U 558   (France)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR;

ADULT; AGED; ALZHEIMER DISEASE; COGNITION; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FUNCTIONAL DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL;

EID: 34547194399     PISSN: 12797707     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (8)

1. Helmer C, Andrieu S, Peres R, Orgogozo JM, Vellas B, Dartigues JF. Predictive Value of 6-Month Decline in ADAS-cog for Survival without Severe Alzheimer's Disease. Dement Geriatr Cogn Disord. 2007 Jan 11;23(3):168-174
2. Vellas B, Andrieu S, Sampaio C, Wilcock G; European Task Force group. Disease-modifying trials in Alzheimer's disease: a European task force consensus. Lancet Neurol. 2007 Jan;6(1):56-62
3. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry 1984;141:1356-1364.
4. Gillette-Guyonnet S, Nourhashemi F, Andrieu S et al. The REAL.FR research program on Alzheimer's disease and its management: methods and preliminary results. J Nutr Health Aging 2003;7:91-96.
5. American Psychiatry Association. Diagnosis and Statistical Manual of Mental Disorders, 4th ed (DSM-IV). In: APA, ed. Washington DC, 1994.
6. Mc Khann G, Drachman D, Folstein M et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
7. Folstein MF, Folstein SE, McHugh PR. Mini Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-192.
8. F. Cortes et al. Six and 18-month Changes in Mild to Moderate Alzheimer's Patients Treated with Acetylcholinesterase Inhibitors: What Can we Learn for Clinical Outcomes of Therapeutic trials? J Nutr Health Aging 2007, 11, 4: 330-337.